OptimizeRx (OPRX)

• Market cap: $273M
• 1 day: -5.18%
• 5 days: -5.25%
• 1 month: 29.61%
• 3 months: 99.58%
• 6 months: 185.97%
• Year to date: 173.90%
• 1 year: 28.33%
• 5 years: 11.14%
• 10 years: 37.21%
• Sector: Healthcare
• Industry: Health Information Services

About: OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

Employees: 129

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

84% more capital invested

Capital invested by funds: $55.3M [Q4 2024] → $102M (+$46.4M) [Q1 2025]

12% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 17

1.74% more ownership

Funds ownership: 61.72% [Q4 2024] → 63.47% (+1.74%) [Q1 2025]

0% more funds holding

Funds holding: 87 [Q4 2024] → 87 (+0) [Q1 2025]

11% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 27

61% less call options, than puts

Call options by funds: $1.02M | Put options by funds: $2.62M

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $14 2% downside
• Avg. target: $15 5% upside
• High target: $16 12% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Stifel David Grossman	12% upside $16	Buy Maintained	9 Jun 2025
JMP Securities Constantine Davides	2% downside $14	Market Outperform Maintained	13 May 2025